CAPITOL CITY GROUP, LTD.

Lobbying for ARDELYX, INC. · discovering, developing and commercializing medicine

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Assist client with matters re: kidney dialysis drugs and renal drugs; assist client with medicare/CMS issues; assist re: issues on ESRD related drugs and medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.